CIK 0001735438
- Non-accelerated filer
- Smaller reporting company
MeiraGTx Holdings plc
Sign in to watch- Ticker
- MGTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981448305
- Phone
- +1 646-860-7985
- Business address
- 655 THIRD AVENUE, SUITE 1115, NEW YORK, NY, 10017
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CHIEF MEDICAL OFFICER bought 5,000 shares at an average $7.90 ($39,500)
- 4 Open-market buy GENERAL COUNSEL AND SECRETARY bought 1,000 shares at $7.94 ($7,940)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes President and CEO gave up 51,554 shares (to pay taxes)
- 4 Shares withheld for taxes CFO & COO gave up 39,657 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Development Officer gave up 37,600 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale President and CEO sold 30,000 shares at an average $19.92 ($597,472)
- 4 Open-market sale CFO & COO sold 22,000 shares at an average $20.99 ($461,777)
- 4 Open-market sale President and CEO sold 30,000 shares at an average $17.36 ($520,687)
Page 8 of 13 · 260 filings